Navigation Links
Caliper Life Sciences' Second Quarter 2010 Financial Results Conference Call Notice
Date:7/20/2010

HOPKINTON, Mass., July 20 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) will conduct a conference call discussing the company's second quarter 2010 financial results at 9:00 a.m. ET on Tuesday, August 3.  Kevin Hrusovsky, President and Chief Executive Officer and Peter McAree, Chief Financial Officer, will host the call. Management will discuss operational and financial results and the company's outlook for the future.

A news release discussing Caliper's second quarter 2010 financial results will be issued Tuesday, August 3 at approximately 7:00 a.m. ET.

Participants please call 888.680.0879 five to ten minutes prior to the call and use the participant passcode of 25038927.  International callers can access the call by dialing 617.213.4856 and entering the same passcode.  You may also pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=PBB39JLCM.

A live webcast of the call can be accessed at www.fulldisclosure.com or on the Caliper website at www.caliperLS.com in the Events section of the Investor Relations page. A webcast replay of the call will remain available until Caliper's earnings call for the third quarter of 2010.

Telephone replays of the conference call will be available approximately two hours after the completion of the call. To access a telephone playback of the proceedings from August 3 through August 10, dial 888.286.8010 and use the participant passcode of 89816817.  International callers can access the playback by dialing 617.801.6888 and using the same participant passcode.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results, enabling the translation of those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
2. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
3. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
4. Caliper Life Sciences to Present at UBS Global Life Sciences Conference
5. Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays
6. Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice
7. Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
8. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
9. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
10. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
11. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... ... $200M operational capacity with its strategic internal leadership to provide clients with ... and operational management. With office locations in North Carolina, Massachusetts, Ohio, ...
(Date:2/21/2017)... -- Lexus, a returning partner of the Amgen Tour of California ... partner of the men,s and women,s events for the next five ... Tour of California will mark the start ... professional cycling teams in the world racing from Northern to ... Breakaway from Heart Disease TM Women,s Race empowered with ...
(Date:2/21/2017)... Research and Markets has announced the addition of the "Global ... 2025" report to their offering. ... The Global Bioplastics & Biopolymers Market is ... next decade to reach approximately $8.9 billion by 2025. ... all the given segments on global as well as regional levels ...
(Date:2/20/2017)... , Feb. 20, 2017 This report analyzes ... the following Product Types: Xylanase, Amylase, Cellulase, and Others. The ... Canada , Japan , ... Latin America , and Rest of World. ... Annual estimates and forecasts are provided for the period 2015 ...
Breaking Biology Technology:
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 ... Family of Companies (Avamere Health Services, Infinity Rehab, Signature ... research study that will apply the power of IBM ... living and health centers. By analyzing data streaming from ... insights into physical and environmental conditions, and obtain deeper ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
Breaking Biology News(10 mins):